Eupraxia Pharmaceuticals Inc. carries a market capitalization of 108.29M, placing it among publicly traded companies globally.
| Market Cap | 108.29M |
| Enterprise Value | N/A |
Eupraxia Pharmaceuticals Inc.'s stock has declined approximately -31.99105% over the past 52 weeks. The 50-day moving average sits at 4.30, while the 200-day moving average is 4.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | -31.99105% |
| 50-Day Moving Average | 4.30 |
| 200-Day Moving Average | 4.80 |
| Average Volume (20 Days) | N/A |